D.E. Shaw & Co
BCAB

D.E. Shaw & Co’s BIOATLA INC BCAB Stock Holding History

D.E. Shaw & Co’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,312
Closed -$614K – 5184
2022
Q2 		$614K Sell
4,312
-1,725
-29% -$275K ﹤0.01% 3978
2022
Q1 		$1.51M Buy
6,037
+5,442
+915% +$2.28M ﹤0.01% 3571
2021
Q4 		$584K Buy
+595
New +$761K ﹤0.01% 4316

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

D.E. Shaw & Co's BCAB Position: Q3 2022 in Review

D.E. Shaw & Co sold out of BIOATLA INC (BCAB) in Q3 2022, closing a stake of 4,312 shares — an estimated $614K sold.

D.E. Shaw & Co first reported a position in BCAB in Q4 2021 and held it in 3 quarters. The position peaked at $1.51M in Q1 2022. 73 funds tracked by Wall St. Rank hold BCAB as of Q3 2022.

  • D.E. Shaw & Co reported no remaining BIOATLA INC position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 4,312 BIOATLA INC shares in Q3 2022, an estimated $614K.
  • D.E. Shaw & Co first reported a position in BIOATLA INC in Q4 2021 and held it in 3 quarters.
  • D.E. Shaw & Co's BIOATLA INC position peaked at $1.51M in Q1 2022.
  • 73 funds tracked by Wall St. Rank held BIOATLA INC as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.